Original paper
Radiotherapy for supratentorial low-grade gliomas: results and prognostic factors with special focus on tumour volume parameters

https://doi.org/10.1016/0167-8140(93)90130-ZGet rights and content

Abstract

From 1973 to 1990, 67 patients with a diagnosis of low-grade glioma were treated in our hospital. Overall survival was analysed as well as the influence of patient, tumour- and treatment-related factors with special focus on tumour volume parameters. Our study group included 49 patients treated by surgery and post-operative radiotherapy (RT) (40 patients) or post-biopsy irradiation alone (9 patients). Total or almost total resection was performed in 16 patients; partial excision was done in 24. With the available pre-surgery and pre-RT CT-scan and/or MRI images we were able to calculate tumour volumes by measuring the largest tumour dimensions in the three axes D1 D2, D3 and by assuming an ellipsoidal growth (i.e., tumour volume = D1D2D3π6. RT was delivered to involved regions: either the residual tumour volume or the tumour bed. The median RT dose was 56 Gy (45–60, range). The 60- and 90-month overall survival (Kaplan-Meier) was 79% and 67%, respectively. Female sex, >70% Karnofsky (Kf) score, oligodendroglioma and <71 cm3 ( ≈5 cm diameter sphere) tumour residuals before RT were associated with better overall survival rates (p < 0.05, log-rank). However, a Cox proportional hazards model showed that only the histological subtype and Kf significantly determined the patients' outcome: 60-month overall survival of 100%, 62%, 83% and 64% for oligodendrogliomas, mixed oligo-astrocytomas and grade-I and grade-II astrocytomas, respectively. The primary tumour volume did not predict survival. Small residual tumour volumes before RT were, however, associated with a better outcome, although they were strongly related with the more favorable oligodendroglioma histologic subtype. Non-pilocytic astrocytomas and mixed tumors did not show a significant volume-outcome relationship in our study.

References (22)

  • J.T. Fazekas

    Treatment of grades I and II astrocytomas. The role of radiotherapy

    Int. J. Radiat., Oncol. Biol. Phys.

    (1977)
  • Cited by (37)

    • Extent of resection for high- and low-grade gliomas

      2019, Comprehensive Overview of Modern Surgical Approaches to Intrinsic Brain Tumors
    • Awake craniotomy versus surgery under general anesthesia for resection of intrinsic lesions of eloquent cortex-A prospective randomised study

      2007, Clinical Neurology and Neurosurgery
      Citation Excerpt :

      Preoperative tumor boundaries were defined by both T1 with gadolium and T2 signal abnormalities. The largest tumor dimensions in the three axes (D1, D2, D3) were measured and the tumor volume was calculated by formula V = (D1 × D2 × D3 × π)/6 [13]. A contrast enhanced CT scan/Gad MRI brain was obtained postoperatively after 6–8 weeks to evaluate the extent of resection which was categorized according to the grading reported by Berger and colleagues that is, total/complete tumor resection indicated no residual signal abnormality, subtotal resection indicated <10 cm3 of residue, and partial resection indicated by >10 cm3 of residual tumor [1].

    • Diffuse astrocytoma

      2005, Textbook of Neuro-Oncology
    • Radiotherapy in Low-Grade Gliomas: Cons

      2003, Seminars in Oncology
    • Results of postoperative radiotherapy in lowgrade gliomas

      2002, Reports of Practical Oncology and Radiotherapy
    View all citing articles on Scopus

    Oral presentation at the 11th annual meeting of the European Society for Therapeutic Radiology and Oncology (Malmö, Sweden, September 1992).

    View full text